Signal active
Bio
Gautam is a general partner at TCV (www.tcv.com). Prior to TCV, Gautam was a partner at M13 (www.m13.co). Prior to M13, Gautam was the co-founder and CEO of NatureBox. Gautam is an angel investor in +40 private companies and venture funds. Gautam's investments includes BigCommerce, GoodData, Honest Company, Grammarly, Imperfect Produce, Heap Analytics, Split.io, among many others.
Prior to launching NatureBox, Gautam was a Principal at General Catalyst Partners. While at General Catalyst, he invested in consumer internet and software companies. Gautam joined General Catalyst from Procter and Gamble, where he analyzed brand strategy and consumer preferences for Procter and Gamble's $4.5B North American Fabric Care business unit.
Gautam received a B.S. in Business Administration from Babson College, with a concentration in Entrepreneurial Studies. Gautam serves on the Board of Overseers at Babson.
Location
San Francisco, California, United States, North America
Social
Primary Organization
1995
527
220
213
51-100
Financial Services, Finance, Business Development
Jobs history
1
TCV
General Partner
2021 - Current
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Gautam Gupta is the General Partner at TCV, based in United States, North America. With a background in Financial Services, Gautam Gupta has a rich history of leadership and innovation. Gautam Gupta studied BS Business Administration @ Babson College. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Investment portfolio
3
0
Personal investment
3
Annouced Date | Organization Name | Funding Round | Money Raised |
---|---|---|---|
Jul 25, 2016 | B12 | Series A - B12 | 12.4M |
Oct 19, 2016 | HigherMe | Seed Round - HigherMe | 1.5M |
Jun 20, 2017 | Looka | Seed Round - Looka | 900.0K |
Partner investment
19
Annouced Date | Organization Name | Funding Round | Investor Name | Money Raised |
---|---|---|---|---|
Mar 03, 2022 | - | Series B - Reforge | TCV | 60.0M |
Sep 29, 2022 | Grow Therapy | Series B - Grow Therapy | TCV | 45.0M |
May 18, 2023 | Instawork | Series D - Instawork | TCV | 60.0M |
Mar 27, 2024 | Nourish | Series A - Nourish | TCV | 35.0M |
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity
There is no recent news or activity for this profile.